I continue to find it difficult to understand why some people equate other's comments about being very cautious with Tysabri as "negative"!


If Biogen is so aware of the dangers of Tysabri, then why have they pushed its introduction into the marketplace so fast from the very beginning? They have run into hurdle after hurdle with this drug as more problems surface as each month passes. It's safety has been questioned from the outset and although all drugs have a risk level associated with them, Biogen's method of operation seems to push ahead as fast as they can and worry about the problems afterwards when they show up.

I and others for months have pointed out the concern we have for this drug as it gets used by more and more patients. It isn't being "negative" but simply giving another point of view.

Harry